Investor:
Leadership team:
Dr. Ravit Netzer and Dr. Adi Goldenzweig
Website:
https://www.scala-bio.com/
Scala Biodesign develops advanced computational protein design technologies that help pharmaceutical, chemical, and biotech companies create more accurate, stable, and high-performing proteins. Their cloud-based platform, Scala OS, integrates atomistic modeling, evolutionary data, and AI, the company enables enzyme, antibody, therapeutic protein, and antigen optimization in a single design round.
Grove stands out for its deep-tech conviction and willingness to invest in complex technologies with the potential for real impact and durable, sustainable business models. Their hands-on team brings clarity at every stage, and for Scala, their ability to bridge science, technology, and business has been invaluable.
Dr. Ravit Netzer, Co-Founder & CEO
